9/14/2004

Wyeth Pharmaceuticals won approval for its needle-free kit that reconstitutes factor VIII, an important blood protein that helps form clots. The ReFactor Antihemophilic Factor R2 kit is intended to help patients get regular treatment more quickly and safely for the inherited blood disorder.

Full Story:
NYTimes.com

Related Summaries